Wegovy Slashes the Risk of Heart Attack and Stroke in a Landmark Trial
The drug semaglutide is already widely used for weight loss. Now its maker is presenting new evidence that it can reduce cardiovascular illnesses and deaths. Read this story here. Learn more about your ad choices. Visit podcastchoices.com/adchoices
Science, Spoken · SpokenLayer
November 14, 20236m 49s
Audio is streamed directly from the publisher (dovetail.prxu.org) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
The drug semaglutide is already widely used for weight loss. Now its maker is presenting new evidence that it can reduce cardiovascular illnesses and deaths.
Read this story here.
Learn about your ad choices: dovetail.prx.org/ad-choices